Literature DB >> 8570093

Co-localization of mu-opioid receptor-like and substance P-like immunoreactivities in axon terminals within the superficial layers of the medullary and spinal dorsal horns of the rat.

Y Q Ding1, S Nomura, T Kaneko, N Mizuno.   

Abstract

The presence of mu-opioid receptor-like immunoreactivity (MOR-LI) on axon terminals was confirmed by light and electron microscopy within the superficial layers of the medullary and spinal dorsal horns of the rat. By means of double-immunofluorescence histochemistry, co-localization of MOR-LI and substance P (SP)-LI was occasionally observed in axon terminals within the superficial layers of the dorsal horns.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8570093     DOI： 10.1016/0304-3940(95)11960-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN： 0304-3940            Impact factor:   3.046


  4 in total

1.  A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesic.

Authors:  S E Foran; D B Carr; A W Lipkowski; I Maszczynska; J E Marchand; A Misicka; M Beinborn; A S Kopin; R M Kream
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 2.  Transmitting pain and itch messages: a contemporary view of the spinal cord circuits that generate gate control.

Authors:  João Braz; Carlos Solorzano; Xidao Wang; Allan I Basbaum
Journal:  Neuron       Date:  2014-05-07       Impact factor: 17.173

3.  Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn.

Authors:  Maureen S Riedl; Stephen A Schnell; Aaron C Overland; Anne-Julie Chabot-Doré; Anna M Taylor; Alfredo Ribeiro-da-Silva; Robert P Elde; George L Wilcox; Laura S Stone
Journal:  J Comp Neurol       Date:  2009-04-01       Impact factor: 3.215

4.  Endomorphin-2 is released from newborn rat primary sensory neurons in a frequency- and calcium-dependent manner.

Authors:  Heather L Scanlin; Elizabeth A Carroll; Victoria K Jenkins; Agnieszka Balkowiec
Journal:  Eur J Neurosci       Date:  2008-05-29       Impact factor: 3.386
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.